Status
ACTIVE
Global HQ
California, United States
Countries of investment
- USA
Investment stages
- Seed
- Series A
- Series B
Industries
- Consumer Products
- Media
- Content Creation
- Web3
- Blockchain
- Transport Tech
- Social Networks
About
venBio LLC is a private equity and venture capital firm established in 2011, dedicated to driving innovation and growth within the life sciences sector. With a strategic focus on early, mid, and late-stage investments, venBio leverages its deep expertise in intellectual property, chemistry, manufacturing, and clinical trials to identify and support transformative companies. The firm is committed to fostering advancements that address critical healthcare challenges, ultimately delivering value to investors and improving patient outcomes. Through its extensive network and industry knowledge, venBio positions itself as a key partner in the success of groundbreaking ventures.
venBio LLC is a private equity and venture capital firm established in 2011, dedicated to driving innovation and growth within the life sciences sector. With a strategic focus on early, mid, and late-stage investments, venBio leverages its deep expertise in intellectual property, chemistry, manufacturing, and clinical trials to identify and support transformative companies. The firm is committed to fostering advancements that address critical healthcare challenges, ultimately delivering value to investors and improving patient outcomes. Through its extensive network and industry knowledge, venBio positions itself as a key partner in the success of groundbreaking ventures.
Investment Thesis
Focuses on investments in life sciences and healthcare innovation.
Manager's Experience
With a robust background in life sciences, the fund manager has successfully executed over 50 investments, primarily in North America and Europe. Their strategic approach is characterized by a data-driven methodology, focusing on late-stage venture and growth equity opportunities. Notable exits include several high-profile biotech firms, underscoring their ability to identify and nurture innovative companies. The manager emphasizes a collaborative, operator-first style to bolster portfolio performance and drive value creation.
Team
Robert Adelman
Paul Brooke
Kurt Emster
Corey Goodman
Corey Goodman
Aaron Royston
Vinny Natarajan